Cas 936571-73-2,2(S)-[2(S)-(4-guanidinomethyl-benzoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid

936571-73-2

Post Buying Request

Basic information

Product Name: 2(S)-[2(S)-(4-guanidinomethyl-benzoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid
Synonyms: 2(S)-[2(S)-(4-guanidinomethyl-benzoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid
CAS NO:936571-73-2
Molecular Formula:
Molecular Weight: 439.514
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2(S)-[2(S)-(4-guanidinomethyl-benzoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid(CAS DataBase Reference)
NIST Chemistry Reference: 2(S)-[2(S)-(4-guanidinomethyl-benzoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid(936571-73-2)
EPA Substance Registry System: 2(S)-[2(S)-(4-guanidinomethyl-benzoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid(936571-73-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 936571-73-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

936571-73-2 Suppliers

Recommended suppliers

936571-73-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 936571-73-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,5,7 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 936571-73:
(8*9)+(7*3)+(6*6)+(5*5)+(4*7)+(3*1)+(2*7)+(1*3)=202
202 % 10 = 2
So 936571-73-2 is a valid CAS Registry Number.

936571-73-2Upstream product

936571-73-2Downstream Products

936571-73-2Relevant academic research and scientific papers

Modifications of the GSK3β substrate sequence to produce substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics

Kayser, Katherine J.,Glenn, Matthew P.,Sebti, Said M.,Cheng, Jin Q.,Hamilton, Andrew D.

, p. 2068 - 2073 (2007/10/03)

Amplification, overexpression, and elevated activation of Akt have been detected in many human malignancies making it an important target for cancer therapy. The Akt substrate-binding site offers a large number of potential interactions to an appropriatel

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 936571-73-2